Professional Summary
Professional Overview
Benjamin Kim is a seasoned pharmaceutical executive with extensive experience in clinical development and operations. As the Vice President of Clinical Development at Star Therapeutics, he oversees the company's clinical trial programs and plays a pivotal role in advancing novel therapies to market.
Experience Summary
Current Role
As the Vice President of Clinical Development at Star Therapeutics, Benjamin is responsible for leading the design, implementation, and execution of the company's clinical trial programs. He collaborates closely with cross-functional teams to ensure the seamless progression of drug candidates through various phases of clinical development. Under his leadership, Star Therapeutics has successfully initiated several key clinical trials, positioning the company for future growth and success.
Career Progression
Benjamin brings a wealth of industry experience to his current role. Prior to joining Star Therapeutics, he served as the Vice President of Clinical Development & Operations at Catalyst Biosciences, where he was instrumental in advancing the company's pipeline of promising drug candidates. Before that, he held the position of Executive Medical Director at BioMarin Pharmaceutical Inc., where he played a crucial role in managing the clinical development of rare disease therapies. Earlier in his career, Benjamin served as a Senior Medical Director and an Associate Medical Director at BioMarin and Genentech, respectively, further expanding his expertise in the pharmaceutical industry.
Academic Background
Benjamin holds a medical degree from the University of California, San Francisco (UCSF), where he also completed his residency in Internal Medicine at Northwestern Memorial Hospital. His strong academic background, combined with his extensive clinical experience, has equipped him with a comprehensive understanding of the pharmaceutical industry and the complexities of drug development.
Areas of Expertise
- Clinical trial design and management
- Regulatory affairs and compliance
- Rare disease drug development
- Cross-functional team leadership and collaboration
- Strategic planning and decision-making
- Effective communication and stakeholder management
Professional Impact
Throughout his career, Benjamin has made significant contributions to the advancement of novel therapies in the pharmaceutical industry. His leadership in the design and execution of clinical trials has resulted in the successful progression of several drug candidates, ultimately improving patient outcomes and addressing unmet medical needs. Benjamin's expertise and industry contributions have earned him a respected reputation among his peers, positioning him as a valuable asset to the companies he has served.
Conclusion
With his impressive track record, strong clinical expertise, and proven leadership abilities, Benjamin Kim is well-equipped to drive the success of Star Therapeutics' clinical development initiatives. His commitment to innovation and patient-centric approach make him a valuable asset to the company as it continues to expand its pipeline and bring groundbreaking therapies to the market.
